Skip to content
healthcare.dev

Selegiline Hydrochloride

NDC 62135-694, Selegiline Hydrochloride, tablet, from Chartwell RX, LLC.

Product NDC
62135-694
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074565
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-694 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SELEGILINE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]; Monoamine Oxidase Type B Inhibitor [EPC]; Monoamine Oxidase-B Inhibitors [MoA]

Package NDCNDC-11Package
62135-694-606213506946060 TABLET in 1 BOTTLE (62135-694-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/189ac32d-28b4-47c5-9de6-318e502eff3b

Use it

Look up 62135-694 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-694 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-694. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.